- Female genital malignancies across different years.
| Variables | Total | Year | ||||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
| n (%) | ||||||||
| Total | 200 (100) | 27 (100) | 35 (100) | 35 (100) | 21 (100) | 32 (100) | 31 (100) | 19 (100) |
| Tumours of uterine corpus | 135 (67.5) | 16 (59.3) | 25 (71.4) | 18 (51.4) | 16 (76.2) | 26 (81.3) | 21 (67.7) | 13 (68.4) |
| Ovarian neoplasm | 27 (13.5) | 5 (18.5) | 5 (14.3) | 7 (20.0) | 1 (4.8) | 2 (6.3) | 3 (9.7) | 4 (21.1) |
| Tumour of uterine cervix | 27 (13.5) | 6 (22.2) | 4 (11.4) | 6 (17.1) | 3 (14.3) | 1 (3.1) | 5 (16.1) | 2 (10.5) |
| Valvar and vaginal tumours | 8 (4.0) | 0 (0.0) | 0 (0.0) | 3 (8.6) | 1 (4.8) | 3 (9.4) | 1 (3.2) | 0 (0.0) |
| Gestational trophoblastic neoplasm | 3 (1.5) | 0 (0.0) | 1 (2.9) | 1 (2.9) | 0 (0.0) | 0 (0.0) | 1 (3.2) | 0 (0.0) |